ALSUntangled #70: caffeine

Jessica Hatch; Paul Barkhaus; Benjamin Barnes; Morgan Beauchamp; Michael Benatar; Tulio Bertorini; Robert Bowser; Mark Bromberg; Andrew Brown; Javier Mascias Cadavid; Gregory T. Carter; Nicholas Cole; Jesse Crayle; Mazen Dimachkie; David Ennist; Eva Feldman; Timothy Fullam; Terry Heiman-Patterson; Sartaj Jhooty; Todd Levine; Xiaoyan Li; Isaac Lund; Elise Mallon; Nicholas Maragakis; Christopher McDermott; Gary Pattee; Kaitlyn Pierce; Dylan Ratner; Kim Staats; Paul Wicks; Martina Wiedau; Richard Bedlack

doi:10.1080/21678421.2023.2220742

Back

Journal article

Peer reviewed

ALSUntangled #70: caffeine

Jessica Hatch, Paul Barkhaus, Benjamin Barnes, Morgan Beauchamp, Michael Benatar, Tulio Bertorini, Robert Bowser, Mark Bromberg, Andrew Brown, Javier Mascias Cadavid, …

Amyotrophic lateral sclerosis and frontotemporal degeneration, Vol.ahead-of-print(ahead-of-print), pp.1-5

2023-06-07

DOI: https://doi.org/10.1080/21678421.2023.2220742

Appears in Miller School of Medicine - Latest Publications

Abstract

adenosine

Amyotrophic lateral sclerosis (ALS)

caffeine

coffee

tea

ALSUntangled reviews alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS). Here, we review caffeine which has plausible mechanisms for slowing ALS progression. However, pre-clinical studies are contradictory, and a large case series showed no relationship between caffeine intake and ALS progression rate. While low doses of caffeine are safe and inexpensive, higher doses can cause serious side effects. At this time, we cannot endorse caffeine as a treatment to slow ALS progression.

Metrics

1 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.287 Dietary Stimulants; 1.287.1516 Caffeine
Web Of Science research areas: Clinical Neurology
ESI research areas: Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: ALSUntangled #70: caffeine
Creators: Jessica Hatch - Augusta University
Paul Barkhaus - Medical College of Wisconsin
Benjamin Barnes - Augusta University
Morgan Beauchamp - University of North Carolina at Chapel Hill
Michael Benatar - University of Miami
Tulio Bertorini - University of Tennessee Health Science Center
Robert Bowser - Barrow Neurological Institute
Mark Bromberg - University of Utah
Andrew Brown - University of Miami
Javier Mascias Cadavid - ALS
Gregory T. Carter - Washington State University Spokane
Nicholas Cole - Motor Neurone Disease Association
Jesse Crayle - Washington University in St. Louis
Mazen Dimachkie - University of Kansas
David Ennist - Genex Systems
Eva Feldman - University of Michigan–Ann Arbor
Timothy Fullam - The University of Texas at San Antonio
Terry Heiman-Patterson - Temple University
Sartaj Jhooty - University of North Carolina at Chapel Hill
Todd Levine - Neuroscience Institute
Xiaoyan Li - Duke University
Isaac Lund - 21 Green Hope High School, Cary, NC, USA
Elise Mallon - Duke University
Nicholas Maragakis - Johns Hopkins University
Christopher McDermott - University of Sheffield
Gary Pattee - University of Nebraska Medical Center
Kaitlyn Pierce - University of North Carolina at Chapel Hill
Dylan Ratner - Tulane University
Kim Staats - 28 Staats Life Consulting, Los Angeles, CA, USA
Paul Wicks - Advanced Innovative Engineering
Martina Wiedau - University of California, Los Angeles
Richard Bedlack - Duke University
Publication Details: Amyotrophic lateral sclerosis and frontotemporal degeneration, Vol.ahead-of-print(ahead-of-print), pp.1-5
Publisher: Taylor & Francis
Academic Unit: Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Neuromuscular Disorders Div
Language: English
Resource Type: Journal article
Record Identifier: 991031809017802976